Matsuyama M, Koizumi N, Otsuka A, Kobayashi K, Yagasaki S, Watanabe Y, Zhou J, Nishiyama Y, Matsumoto N, Tsukihara H, Numata K : A novel complementation method of an acoustic shadow region utilizing a convolutional neural network for ultrasound-guided therapy. International Journal of Computer Assisted Radiology and Surgery, 17(1):107-119, 2022.
Chuma M, Uojima H, Hattori N, Arase Y, Fukushima T, Hirose S, Kobayashi S, Ueno M, Tezuka S, Iwasaki S, Wada N, Kubota K, Tsuruya K, Shimma Y, Hiroki I, Takuya E, Tokoro C, Iwase S, Miura Y, Moriya S, Watanabe T, Hidaka H, Morimoto M, Numata K, Kusano C, Kagawa T, Maeda S:Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: a multicenter analysis. Hepatol Res, 52(3):269-280, 2022.
Ogushi K, Chuma M, Numata K, Nozaki A, Moriya S, Uojima H, Kondo M, Morimoto M, Maeda S: Impact of psoas muscle index assessed by a simple measurement method on tolerability and duration of continued treatment with sorafenib in hepatocellular carcinoma patients. Eur J Gastroenterol Hepatol, 34(7):774-781, 2022.
Okada M, Numata K, Nihonmatsu H, Tomita K, Takeda A, Hyodo T, Eriguchi T, Nakano M: Pathological appearance of focal liver reactions after stereotactic body radiotherapy for hepatocellular carcinoma. Diagnostics (Basel), 12(5):1072, 2022.
Kobayashi S, Fukushima T, Ueno M, Moriya S, Chuma M, Numata K, Tsuruya K, Hirose S, Kagawa T, Hattori N, Watanabe T, Matsunaga K, Suzuki M, Uojima H, Hidaka H, Kusano C, Suzuki M, Morimoto M: A Prospective Observational Cohort Study of Lenvatinib as Initial Treatment in Patients with BCLC-Defined Stage B Hepatocellular Carcinoma. BMC cancer, 22(1):517 , 2022.
Chuma M, Yokoo H, Hiraoka A, Ueda K, Yokoyama T, Tsuji K, Shimada N, Uojima H, Kobayashi S, Hattori N, Okubo T, Atsukawa M, Ishikawa T, Takaguchi K, Tsutsui A, Toyoda H, Tada T, Saito Y, Hirose S, Tanaka T, Takeda K, Otani M, Sekikawa Z, Watanabe T, Hidaka H, Morimoto M, Numata K, Kagawa T, Sakamoto M, Kumada T, Maeda S: Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib Treatment. Curr Oncol, 29(5):3259-3271, 2022.
Wang F, Numata K, Komiyama S, Miwa H, Sugimori K, Ogushi K, Moriya S, Nozaki A, Chuma M, Ruan L, Maeda S: Combination Therapy with Lenvatinib and Radiofrequency Ablation for Patients with Intermediate-stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh Class A Liver function: A Pilot Study. Frontiers in Oncology, 12:843680, 2022.
Zhang Y, Numata K, Du Y, Maeda S: Contrast agents for Hepatocellular carcinoma imaging: value and progression. Front Oncol, 12:921667, 2022.
Kawamura A, Uojima H, Chuma M, Shao X, Hidaka H, Nakazawa T, Take A, Sakaguchi Y, Numata K, Kako M, Nozaki A, Azuma S, Horio K, Kusano C, Atsuda K: The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma. BMC Cancer, 22(1):912, 2022.
Numata K, Wang F: New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy. Hepatobiliary Surg Nutr, 11(5):766-769, 2022.
Wang F, Numata K, Nihonmatsu H, Chuma M, Ideno N, Nozaki A, Ogushi K, Tanabe M, Okada M, Luo W, Nakano M, Otani M, Inayama Y, Maeda S: Added Value of Ultrasound-Based Multimodal Imaging to Diagnose Hepatic Sclerosed Hemangioma before Biopsy and Resection. Diagnostics (Basel), 12(11):2818, 2022.
Atsukawa M, Tsubota A, Kondo C, Toyoda H, Nakamuta M, Takaguchi K, Watanabe T, Hiraoka A, Uojima H, Ishikawa T, Iwasa M, Tada T, Nozaki A, Chuma M, Fukunishi S, Asano T, Ogawa C, Abe H, Kato K, Hotta N, Shima T, Matsuura K, Mikami S, Tachi Y, Fujioka S, Okubo H, Shimada N, Tani J, Morishita A, Hidaka I, Moriya A, Tsuji K, Akahane T, Okubo T, Arai T, Kitamura M, Morita K, Kawata K, Tanaka Y, Kumada T, Iwakiri K; KTK49 Liver Study Group: Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis. Hepatol Res, 52(3):235-246, 2022.
Iijima T, Obata S, Chuma M, Miyagi E, Aoki S: Rapid progression of hepatocellular carcinoma in a pregnant woman: A case report. Clin Case Rep,10(11):e6558, 2022.
Ueno M, Sugimori K, Taguri M, Ohkawa S, Kobayashi S, Miwa H, Kaneko T, Morimoto M, Yamanaka T: Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic Cancer. Nutrition and Cancer, 74(1): 123-130, 2022.
Kobayashi S, Suzuki M, Ueno M, Maruki Y, Okano N, Todaka A, Ozaka M, Tsuji K, Shioji K, Doi K, Kojima Y, Tsumura H, Tanaka K, Higuchi H, Kawabe K, Imaoka H, Yamashita T, Miwa H, Nagano H, Arima S, Hayashi H, Naganuma A, Yamaguchi H, Hisano T, Umemoto K, Ishii S, Nakashima K, Suzuki R, Kitano Y, Misumi T, Furuse J, Ishii H: Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer. Oncologist, 27(10):e774-e782, 2022.
Takeda Y, Kobayashi N, Kessoku T, Okubo N, Suzuki A, Tokuhisa M, Miwa H, Udaka N, Ichikawa Y: Case reports: chemoradiotherapy for locally advanced neuroendocrine carcinoma of the gallbladder. Clin J Gastroenterol, 15(4):803-808, 2022.
Yoshida Y, Kobayashi S, Ueno M, Morizane C, Tsuji K, Maruki Y, Mori K, Watanabe K, Ohba A, Furuta M, Todaka A, Tsujimoto A, Ozaka M, Okano N, Yane K, Umemoto K, Kawamoto Y, Terashima T, Tsumura H, Doi K, Shioji K, Asagi A, Kojima Y, Suzuki E, Toshiyama R, Furukawa M, Naganuma A, Suzuki R, Miwa H, Ikeda M, Furuse J: Efficacy of chemotherapy for patients with metastatic or recurrent pancreatic adenosquamous carcinoma: A multicenter retrospective analysis. Pancreatology, 22(8):1159-1166, 2022.
Omoto S, Kitano M, Fukasawa M, Ashida R, Kato H, Shiomi H, Sugimori K, Kanno A, Chiba Y, Takano S, Yamamoto N, Ezaki T, Miwa H, Yokomura A, Hoshikawa M, Tanaka T, Kudo M: Tissue harmonic versus contrast-enhanced harmonic endoscopic ultrasonography for the diagnosis of pancreatic tumors: Prospective multicenter study. Dig Endosc, 34(1):198-206, 2022.
Azemoto N, Ueno M, Yanagimoto H, Mizuno N, Kawamoto Y, Maruki Y, Watanabe K, Suzuki R, Kaneko J, Hisada Y, Sato H, Kobayashi S, Miyata H, Furukawa M, Mizukami T, Miwa H, Ohno Y, Tsuji K, Tsujimoto A, Nagano H, Okuyama H, Asagi A, Okano N, Ishii H, Morizane C, Ikeda M, Furuse J: Endoscopic duodenal stent placement versus gastrojejunostomy for unresectable pancreatic cancer patients with duodenal stenosis before introduction of initial chemotherapy (GASPACHO study): a multicenter retrospective study. Jpn J Clin Oncol, 52(2):134-142, 2022.
Ozeki Y, Hirasawa K, Sawada A, Ikeda R, Nishio M, Fukuchi T, Kobayashi R, Sato C, Maeda S: Learning curve analysis for duodenal endoscopic submucosal dissection: A single-operator experience. J Gastroenterol Hepatol, 37(11):2131-2137, 2022.
Nishio M, Hirasawa K, Ozeki Y, Sawada A, Ikeda R, Fukuchi T, Kobayashi R, Sato C, Ogashiwa T, Inayama Y, Kunisaki R, Maeda S: Magnifying endoscopy is useful for tumor border diagnosis in ulcerative colitis patients. Dig Liver Dis, 54(6):812-818, 2022.
Shichijo S, Takeuchi Y, Shimodate Y, Yamashina T, Yamasaki T, Hayashi T, Hirasawa K, Fukunaga S, Yamaguchi S, Asai S, Kawamura T, Fukata N, Yamamoto M, Teramoto A, Kinjo Y, Matsuno K, Kinjo T, Sano Y, Iwatsubo T, Nagaike K, Matsumoto M, Hoki N, Kawamura I, Shimokawa T, Uedo N, Ishikawa H, Tanaka K, Kitano M; Kansai Endoscopic Device Selection Conference in Kansai Research Group: Performance of perioperative antibiotics against post-endoscopic submucosal dissection coagulation syndrome: a multicenter randomized controlled trial. Gastrointest Endosc, 95(2):349-359, 2022.
Yoshida M, Takizawa K, Hasuike N, Ono H, Boku N, Kadota T, Mizusawa J, Oda I, Yoshida N, Horiuchi Y, Hirasawa K, Morita Y, Yamamoto Y, Muto M; Gastrointestinal Endoscopy Group of the Japan Clinical Oncology Group: Second gastric cancer after curative endoscopic resection of differentiated-type early gastric cancer: post-hoc analysis of a single-arm confirmatory trial. Gastrointest Endosc, 95(4):650-659, 2022.
Takimoto K, Matsuura N, Nakano Y, Tsuji Y, Takizawa K, Morita Y, Nagami Y, Hirasawa K, Araki H, Yamaguchi N, Aoyagi H, Matsuhashi T, Iizuka T, Saegusa H, Yamazaki K, Hori S, Mannami T, Hanaoka N, Mori H, Kobara H, Takeuchi Y, Ono H; Polyglycolic Acid Study Group: Efficacy of polyglycolic acid sheeting with fibrin glue for perforations related to gastrointestinal endoscopic procedures: a multicenter retrospective cohort study. Surg Endosc, 36(7):5084-5093, 2022.
Ikeda R, Hirasawa K, Ozeki Y, Sawada A, Nishio M, Fukuchi T, Sato C, Maeda S: Cervical esophageal adenocarcinoma of intestinal type in ectopic gastric mucosa. DEN Open, 18;3(1):e141, 2022.
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial:Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Lancet, 2023 Oct 20:S0140-6736(23)01796-8.
Impact of body composition for patients with hepatocellular carcinoma who received atezolizumab plus bevacizumab therapy: Uojima H, Chuma M, Hidaka H, Tsuda T, Kobayashi S, Hattori N, Ogushi K, Arase Y, Take A, Sakaguchi Y, Tomoko A, Nishigori S, Wanatanbe T, Numata K, Morimoto M, Kagawa T, Kako M, Kusano C. Eur J Gastroenterol Hepatol, 2023 Aug 1;35(8):865-873.
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study: Kato N, Kudo M, Tsuchiya K, Hagihara A, Numata K, Aikata H, Inaba Y, Kondo S, Motomura K, Okano N, Ikeda M, Morimoto M, Kuroda S, Kimura A. Hepatol Res, 2023 May;53(5):409-416.
Multicenter retrospective study of stereotactic body radiotherapy for patients with previously untreated initial small hepatocellular carcinoma: Doi Y, Nagata Y, Matsumoto Y, Numata K, Sasaki R, Yamada T, Igaki H, Imagumbai T, Katoh N, Yoshitake T, Shimizuguchi T, Fujioka D, Inoue M, Koide Y, Kimura T, Ito Y. Hepatol Res, 2023 Aug;53(8):749-760.
Study on method of organ section retention and tracking through deep learning in automated diagnostic and therapeutic robotics: Fujibayashi T, Koizumi N, Nishiyama Y, Watanabe Y, Zhou J, Matsuyama M, Yamada M, Tsumura R, Yoshinaka K, Matsumoto N, Tsukihara H, Numata K. Int J Comput Assist Radiol Surg, 2023 Nov;18(11):2101-2109.
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: Fukushima T, Morimoto M, Kobayashi S, Ueno M, Uojima H, Hidaka H, Kusano C, Chuma M, Numata K, Tsuruya K, Arase Y, Kagawa T, Hattori N, Ikeda H, Watanabe T, Tanaka K, Maeda S. Oncologist, 2023 Jul 5;28(7):e526-e533.
Fib-4 index predicts prognosis after achievement of sustained virologic response following direct-acting antiviral treatment in patients with hepatitis C virus infection: Ideno N, Nozaki A, Chuma M, Ogushi K, Hara K, Moriya S, Fukuda H, Numata K, Maeda S. Eur J Gastroenterol Hepatol, 2023 Feb 1;35(2):219-226.
Wang F, Numata K, Liang H, Tsuchiya H, Ruan L, Tanabe M, Bai X: The value of contrast-enhanced ultrasonography and contrast-enhanced computed tomography in the diagnosis of hepatic angiosarcoma. Frontiers in Oncology in press.
Nishio M, Hirasawa K, Chiba S, Ozeki Y, Sawada A, Ikeda R, Fukuchi T, Kobayashi R, Sato C, Inayama Y, Kunisaki R, Maeda S. Scand J Gastroenterol, 2023 Jan;58(1):101-106.
Vessel images of gallbladder polypoid lesions on detective flow imaging endoscopic ultrasonography: Miwa H, Sugimori K, Maeda S. Dig Endosc, 2023 May;35(4):e61-e62.
Usefulness of the two-devices-in-one-channel technique for difficult bile duct intubation in patients without periampullary diverticulum: Kaneko T, Sugimori K, Endo K, Nishimura M, Tozuka Y, Miwa H, Maeda S: Endoscopy, 2023 Dec;55(S 01):E76-E77.
Cholangioscopy in IgG4-related sclerosing cholangitis using texture and color enhancement imaging and red dichromatic imaging: Ishii T, Kaneko T, Murakami A, Enomoto M, Sugimori K, Kawana I, Maeda S. Endoscopy, 2023 Dec;55(S 01):E1019-E1020.
Endoscopic Resection with One-Port Placement: A Newly Developed Technique for the Safe Management of Advanced Endoscopic Resection for Gastric Gastrointestinal Stromal Tumors:Sawada A, Hirasawa K, Sato C, Sato S, Sato T, Sugimori K, Kunisaki C, Maeda S. Digestion, 2023 Aug 30:1-8.